Tailored Diabetes Care: Customizing Management Strategies Across Life Stages

Opinion
Video

Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Dexcom G7 15 Day CGM System Cleared by FDA / image credit ©Waldenmarus/stock.adobe.com

Dexcom G7 15 Day CGM System Cleared by FDA

Grace Halsey
April 10th 2025
Article

The extended wear benefit is augmented by the G7 15 Day CGM system's superior evidence-based accuracy, with a MARD of 8.0%

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program / image credit ©Centers for Disease Control and Prevention

Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program

March 19th 2025
Article

The 30-year program has tracked and compiled data on diabetes prevention, treatment, and outcomes, providing a foundation and insights for international research.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care

Sydney Jennings
March 14th 2025
Article

The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with T1D in a small study.

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves First Rapid-Acting Insulin Biosimilar for Diabetes: Daily Dose

Sydney Jennings
March 3rd 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.